Global Naftopidil Market Research Report 2024

Publication ID:

PB505248165

Publication Date:

May 30, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Naftopidil is a medication that belongs to the class of drugs known as alpha-1 adrenergic receptor antagonists. It is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. Naftopidil works by relaxing the smooth muscles in the prostate and bladder neck, which helps to improve urinary flow and reduce symptoms such as difficulty urinating, frequent urination, and incomplete emptying of the bladder. It may also be prescribed for the treatment of hypertension (high blood pressure) in some cases.
The global Naftopidil market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Naftopidil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Naftopidil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Naftopidil include Sinopharm Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Aurobindo Pharma, Erregierre, Jeil Pharmaceutical, Mylan Laboratories, RA Chem Pharma, Syn-Tech Chem & Pharm and Procos, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Naftopidil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naftopidil.
Report Scope
The Naftopidil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Naftopidil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naftopidil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sinopharm Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Aurobindo Pharma
Erregierre
Jeil Pharmaceutical
Mylan Laboratories
RA Chem Pharma
Syn-Tech Chem & Pharm
Procos
Sagami Chemical Industry
Daito Pharmaceutical
Iwaki Seiyaku
Hainan Simcere Pharmaceutical
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naftopidil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naftopidil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Naftopidil Market Overview
1.1 Product Overview and Scope of Naftopidil
1.2 Naftopidil Segment by Type
1.2.1 Global Naftopidil Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.3 Naftopidil Segment by Application
1.3.1 Global Naftopidil Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Naftopidil Market Size Estimates and Forecasts
1.4.1 Global Naftopidil Revenue 2019-2030
1.4.2 Global Naftopidil Sales 2019-2030
1.4.3 Global Naftopidil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Naftopidil Market Competition by Manufacturers
2.1 Global Naftopidil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Naftopidil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Naftopidil Average Price by Manufacturers (2019-2024)
2.4 Global Naftopidil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Naftopidil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naftopidil, Product Type & Application
2.7 Naftopidil Market Competitive Situation and Trends
2.7.1 Naftopidil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Naftopidil Players Market Share by Revenue
2.7.3 Global Naftopidil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Naftopidil Retrospective Market Scenario by Region
3.1 Global Naftopidil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Naftopidil Global Naftopidil Sales by Region: 2019-2030
3.2.1 Global Naftopidil Sales by Region: 2019-2024
3.2.2 Global Naftopidil Sales by Region: 2025-2030
3.3 Global Naftopidil Global Naftopidil Revenue by Region: 2019-2030
3.3.1 Global Naftopidil Revenue by Region: 2019-2024
3.3.2 Global Naftopidil Revenue by Region: 2025-2030
3.4 North America Naftopidil Market Facts & Figures by Country
3.4.1 North America Naftopidil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Naftopidil Sales by Country (2019-2030)
3.4.3 North America Naftopidil Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Naftopidil Market Facts & Figures by Country
3.5.1 Europe Naftopidil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Naftopidil Sales by Country (2019-2030)
3.5.3 Europe Naftopidil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naftopidil Market Facts & Figures by Country
3.6.1 Asia Pacific Naftopidil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Naftopidil Sales by Country (2019-2030)
3.6.3 Asia Pacific Naftopidil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Naftopidil Market Facts & Figures by Country
3.7.1 Latin America Naftopidil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Naftopidil Sales by Country (2019-2030)
3.7.3 Latin America Naftopidil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naftopidil Market Facts & Figures by Country
3.8.1 Middle East and Africa Naftopidil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Naftopidil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Naftopidil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naftopidil Sales by Type (2019-2030)
4.1.1 Global Naftopidil Sales by Type (2019-2024)
4.1.2 Global Naftopidil Sales by Type (2025-2030)
4.1.3 Global Naftopidil Sales Market Share by Type (2019-2030)
4.2 Global Naftopidil Revenue by Type (2019-2030)
4.2.1 Global Naftopidil Revenue by Type (2019-2024)
4.2.2 Global Naftopidil Revenue by Type (2025-2030)
4.2.3 Global Naftopidil Revenue Market Share by Type (2019-2030)
4.3 Global Naftopidil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Naftopidil Sales by Application (2019-2030)
5.1.1 Global Naftopidil Sales by Application (2019-2024)
5.1.2 Global Naftopidil Sales by Application (2025-2030)
5.1.3 Global Naftopidil Sales Market Share by Application (2019-2030)
5.2 Global Naftopidil Revenue by Application (2019-2030)
5.2.1 Global Naftopidil Revenue by Application (2019-2024)
5.2.2 Global Naftopidil Revenue by Application (2025-2030)
5.2.3 Global Naftopidil Revenue Market Share by Application (2019-2030)
5.3 Global Naftopidil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sinopharm Weiqida Pharmaceutical
6.1.1 Sinopharm Weiqida Pharmaceutical Corporation Information
6.1.2 Sinopharm Weiqida Pharmaceutical Description and Business Overview
6.1.3 Sinopharm Weiqida Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sinopharm Weiqida Pharmaceutical Naftopidil Product Portfolio
6.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments/Updates
6.2 Shanghai Shyndec Pharmaceutical
6.2.1 Shanghai Shyndec Pharmaceutical Corporation Information
6.2.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.2.3 Shanghai Shyndec Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Shyndec Pharmaceutical Naftopidil Product Portfolio
6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Naftopidil Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Erregierre
6.4.1 Erregierre Corporation Information
6.4.2 Erregierre Description and Business Overview
6.4.3 Erregierre Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Erregierre Naftopidil Product Portfolio
6.4.5 Erregierre Recent Developments/Updates
6.5 Jeil Pharmaceutical
6.5.1 Jeil Pharmaceutical Corporation Information
6.5.2 Jeil Pharmaceutical Description and Business Overview
6.5.3 Jeil Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jeil Pharmaceutical Naftopidil Product Portfolio
6.5.5 Jeil Pharmaceutical Recent Developments/Updates
6.6 Mylan Laboratories
6.6.1 Mylan Laboratories Corporation Information
6.6.2 Mylan Laboratories Description and Business Overview
6.6.3 Mylan Laboratories Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Laboratories Naftopidil Product Portfolio
6.6.5 Mylan Laboratories Recent Developments/Updates
6.7 RA Chem Pharma
6.6.1 RA Chem Pharma Corporation Information
6.6.2 RA Chem Pharma Description and Business Overview
6.6.3 RA Chem Pharma Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 RA Chem Pharma Naftopidil Product Portfolio
6.7.5 RA Chem Pharma Recent Developments/Updates
6.8 Syn-Tech Chem & Pharm
6.8.1 Syn-Tech Chem & Pharm Corporation Information
6.8.2 Syn-Tech Chem & Pharm Description and Business Overview
6.8.3 Syn-Tech Chem & Pharm Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Syn-Tech Chem & Pharm Naftopidil Product Portfolio
6.8.5 Syn-Tech Chem & Pharm Recent Developments/Updates
6.9 Procos
6.9.1 Procos Corporation Information
6.9.2 Procos Description and Business Overview
6.9.3 Procos Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Procos Naftopidil Product Portfolio
6.9.5 Procos Recent Developments/Updates
6.10 Sagami Chemical Industry
6.10.1 Sagami Chemical Industry Corporation Information
6.10.2 Sagami Chemical Industry Description and Business Overview
6.10.3 Sagami Chemical Industry Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sagami Chemical Industry Naftopidil Product Portfolio
6.10.5 Sagami Chemical Industry Recent Developments/Updates
6.11 Daito Pharmaceutical
6.11.1 Daito Pharmaceutical Corporation Information
6.11.2 Daito Pharmaceutical Naftopidil Description and Business Overview
6.11.3 Daito Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Daito Pharmaceutical Naftopidil Product Portfolio
6.11.5 Daito Pharmaceutical Recent Developments/Updates
6.12 Iwaki Seiyaku
6.12.1 Iwaki Seiyaku Corporation Information
6.12.2 Iwaki Seiyaku Naftopidil Description and Business Overview
6.12.3 Iwaki Seiyaku Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Iwaki Seiyaku Naftopidil Product Portfolio
6.12.5 Iwaki Seiyaku Recent Developments/Updates
6.13 Hainan Simcere Pharmaceutical
6.13.1 Hainan Simcere Pharmaceutical Corporation Information
6.13.2 Hainan Simcere Pharmaceutical Naftopidil Description and Business Overview
6.13.3 Hainan Simcere Pharmaceutical Naftopidil Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hainan Simcere Pharmaceutical Naftopidil Product Portfolio
6.13.5 Hainan Simcere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naftopidil Industry Chain Analysis
7.2 Naftopidil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naftopidil Production Mode & Process
7.4 Naftopidil Sales and Marketing
7.4.1 Naftopidil Sales Channels
7.4.2 Naftopidil Distributors
7.5 Naftopidil Customers
8 Naftopidil Market Dynamics
8.1 Naftopidil Industry Trends
8.2 Naftopidil Market Drivers
8.3 Naftopidil Market Challenges
8.4 Naftopidil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sinopharm Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Aurobindo Pharma
Erregierre
Jeil Pharmaceutical
Mylan Laboratories
RA Chem Pharma
Syn-Tech Chem & Pharm
Procos
Sagami Chemical Industry
Daito Pharmaceutical
Iwaki Seiyaku
Hainan Simcere Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂